AAAAAA

   
Results: 1-10 |
Results: 10
Equivalent racial outcome after conformal radiotherapy for prostate cancer: A single departmental experience
Authors: Connell, PP Ignacio, L Haraf, D Awan, AM Halpern, H Abdalla, I Nautiyal, J Jani, AB Weichselbaum, RR Vijayakumar, S
Citation: Pp. Connell et al., Equivalent racial outcome after conformal radiotherapy for prostate cancer: A single departmental experience, J CL ONCOL, 19(1), 2001, pp. 54-61
Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era
Authors: Jani, AB Vaida, F Hanks, G Asbell, S Sartor, O Moul, JW Roach, M Brachman, D Kalokhe, U Muller-Runkel, R Ray, P Ignacio, L Awan, A Weichselbaum, RR Vijayakumar, S
Citation: Ab. Jani et al., Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era, INT J CANC, 96(6), 2001, pp. 363-371
Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trial
Authors: Chung, TDK Park, II Ignacio, L Catchatourian, R Kopnick, M Davison, E Conrad, G Awan, AM Crawford, D Vijayakumar, S
Citation: Tdk. Chung et al., Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trial, INT J CANC, 90(5), 2000, pp. 302-304
Self-assessed health-related quality of life in men who have completed radiotherapy for prostate cancer: Instrument validation and its relation to patient-assessed bother of symptoms
Authors: Wang, H Huang, E Dale, W Campbell, T Ignacio, L Kopnick, M Ray, P Vijayakumar, S
Citation: H. Wang et al., Self-assessed health-related quality of life in men who have completed radiotherapy for prostate cancer: Instrument validation and its relation to patient-assessed bother of symptoms, INT J CANC, 90(3), 2000, pp. 163-172
Potency preservation following conformal radiotherapy for localized prostate cancer: Impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors
Authors: Mantz, CA Nautiyal, J Awan, A Kopnick, M Ray, P Kandel, G Niederberger, C Ignacio, L Dawson, E Fields, R Weichselbaum, R Vijayakumar, S
Citation: Ca. Mantz et al., Potency preservation following conformal radiotherapy for localized prostate cancer: Impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors, CA J SCI AM, 5(4), 1999, pp. 230-236
Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer
Authors: Chen, LM Ignacio, L Jacobs, R Kozloff, M Telfer, M Elahi, R Evans, R Vijayakumar, S
Citation: Lm. Chen et al., Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer, RADIAT ON I, 7(1), 1999, pp. 49-53
Caution in interpreting biochemical control rates after treatment for prostate cancer: Length of follow-up influences results
Authors: Connell, PP Ignacio, L McBride, RB Weichselbaum, RR Vijayakumar, S
Citation: Pp. Connell et al., Caution in interpreting biochemical control rates after treatment for prostate cancer: Length of follow-up influences results, UROLOGY, 54(5), 1999, pp. 875-879
PSA-based outcome analysis after radiation therapy for prostate cancer: A new definition of biochemical failure after intervention
Authors: Jani, AB Chen, MH Vaida, F Ignacio, L Awan, A Weichselbaum, RR Vijayakumar, S
Citation: Ab. Jani et al., PSA-based outcome analysis after radiation therapy for prostate cancer: A new definition of biochemical failure after intervention, UROLOGY, 54(4), 1999, pp. 700-705
Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: Instrument validation and its relation to patient-assessed bother of symptoms
Authors: Dale, W Campbell, T Ignacio, L Song, P Kopnick, M Mamo, C Ray, P Vijayakumar, S
Citation: W. Dale et al., Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: Instrument validation and its relation to patient-assessed bother of symptoms, UROLOGY, 53(2), 1999, pp. 359-366
Effect of subcutaneous recombinant human erythropoetin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial
Authors: Sweeney, PJ Nicolae, D Ignacio, L Chen, L Roach, M Wara, W Marcus, KC Vijayakumar, S
Citation: Pj. Sweeney et al., Effect of subcutaneous recombinant human erythropoetin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial, BR J CANC, 77(11), 1998, pp. 1996-2002
Risultati: 1-10 |